![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1531955
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Pancreaticoduodenectomy (PD) involves resecting multiple organs and reconstructing the digestive tract, including pancreatico-enteric, bilioenteric, and gastroenteric anastomoses. Previous studies have shown a high incidence of long-term complications after PD, impacting patient prognosis and survival. The mechanisms remain unclear, but biliary-intestinal anastomosis may alter bile flow and affect gut microbiota and its metabolites. Given the link between biliary tract infections and gut microbiota changes, we hypothesize that post-PD alterations in intestinal flora and metabolites could contribute to long-term complications.This study included 17 patients who underwent PD (Group T) and 20 matched controls (Group N). Group T was further divided into complication and non-complication subgroups. Fecal samples were collected for 16S rRNA gene sequencing to analyze microbial composition and metabolites. Results showed: 1. No significant differences in alpha diversity indices between groups. 2. Group T had higher levels of Escherichia-Shigella, Veillonella, and Enterobacter, and lower levels of Blautia and Bifidobacterium compared to Group N. 3. Escherichia-Shigella correlated negatively with Blautia, positively with Veillonella and Enterobacter. Blautia and Bifidobacterium correlated positively with each other. 4. The complication subgroup had significantly higher Escherichia-Shigella levels. 5. Metabolomic analysis revealed increased L-palmitoylcarnitine, arachidic acid, and PG 13:0_15:0 in Group T, while 3-isopropylmalic acid decreased. 6. KEGG pathway analysis identified nine metabolic pathways associated with these shifts. Conclusion: 1. Biliary-intestinal anastomosis during PD alters intestinal flora. 2. Increased Escherichia-Shigella abundance may promote long-term complications. 3. Post-PD biliary-intestinal anastomosis affects metabolite profiles. 4. Altered intestinal flora and metabolites may contribute to long-term complications via specific metabolic pathways.
Keywords: intestinal flora, Flora Metabolites, Biliary-intestinal anastomosis, Long-term postoperative complications, Escherichia-Shigella
Received: 22 Nov 2024; Accepted: 13 Feb 2025.
Copyright: © 2025 Li, Chen, Ning, Wang, Chen, Xingdong and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhao Chen, Second Affiliated Hospital of Dalian Medical University, Dalian, China
Shili Ning, Second Affiliated Hospital of Dalian Medical University, Dalian, China
Bowei Lu, Second Affiliated Hospital of Dalian Medical University, Dalian, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.